Spelling suggestions: "subject:"interleukin 6"" "subject:"lnterleukin 6""
101 |
Modulation of the ACTH response to stress by IL-6, nitric oxide, diet and exerciseJankord, Ryan, January 2006 (has links)
Thesis (Ph. D.)--University of Missouri-Columbia, 2006. / The entire dissertation/thesis text is included in the research.pdf file; the official abstract appears in the short.pdf file (which also appears in the research.pdf); a non-technical general description, or public abstract, appears in the public.pdf file. Vita. "December 2006" Includes bibliographical references.
|
102 |
Deneysel omurilik yaralanmasında İnterlökin-10'un İnterlökin 1-Beta ve İnterlökin-6 üzerine etkilerinin incelenmesi /Aydın, Gönül. Karaaslan, Tamer. January 2007 (has links) (PDF)
Tez (Tıpta Uzmanlık) - Süleyman Demirel Üniversitesi, Tıp Fakültesi, Beyin Cerrahi Anabilim Dalı, 2007. / Bibliyografya var.
|
103 |
Effects of concentric and eccentric muscle contractions on IL-6 signaling in human skeletal muscle and downstream regulation of HSP-72 gene expression Is IL-6 signaling involved in exercise-induced cytoprotection? /Harvey, Travis. Willoughby, Darryn Scott, January 2008 (has links)
Thesis (Ph.D.)--Baylor University, 2008. / Includes bibliographical references (p. 131-148).
|
104 |
Effect of microbial lipopolysaccharide and inflammatory cytokines on IL-6 induction by human gingival fibroblasts from healthy and periodontally diseased tissueKent, Leigh Whitfield. January 1997 (has links)
Thesis (Ph. D.)--University of Alabama at Birmingham, School of Joint Health Sciences, 1997. / eContent provider-neutral record in process. Description based on print version record. Includes bibliographical references.
|
105 |
Effect of microbial lipopolysaccharide and inflammatory cytokines on IL-6 induction by human gingival fibroblasts from healthy and periodontally diseased tissueKent, Leigh Whitfield. January 1997 (has links)
Thesis (Ph. D.)--University of Alabama at Birmingham, School of Joint Health Sciences, 1997. / Includes bibliographical references.
|
106 |
Untersuchungen zur Zytokinbindung und Rezeptoraktivierung des Signaltransduktors gp130 durch seine Liganden IL-6 und IL-11Kurth, Ingo. Unknown Date (has links) (PDF)
Techn. Hochsch., Diss., 2003--Aachen.
|
107 |
Funktion der Protein-Tyrosin-Phosphatase SHP2 bei der Interleukin 6 vermittelten Akutphase Genregulation und T-Zell-MigrationWeißenbach, Manuela. Unknown Date (has links) (PDF)
Techn. Hochsch., Diss., 2002--Aachen.
|
108 |
Ethnic differences in diurnal blood pressure variation and regulation the effects of catecholamines, cortisol, and IL-6 /Van Berge-Landry, Helene Margaret-Rose. January 2008 (has links)
Thesis (Ph. D.)--State University of New York at Binghamton, Department of Anthropology, 2008. / Includes bibliographical references.
|
109 |
Interleucina-6 na endometriose : concentrações no fluído peritoneal e expressão proteica no tecido endometrialOrtiz, Karine Silveira January 2017 (has links)
A endometriose é uma doença ginecológica crônica que afeta pelo menos 10% das mulheres em idade reprodutiva. É caracterizada pelo crescimento de tecido endometrial fora da cavidade uterina. Embora sua etiologia permaneça controversa, estudos propõem que alterações imunológicas e inflamatórias estão correlacionadas com a causa da endometriose e podem contribuir para o crescimento e sobrevida de implantes ectópicos. Como parte integrante desse processo, um microambiente peritoneal anormal pode ser constituído por níveis aumentados de células imunológicas. Dentre estas, a elevação de citocinas pró-inflamatórias no ambiente peritoneal e sistêmico participariam desse processo. Citocinas incluindo a interleucina-6 (IL-6), uma glicoproteína com atuação na resposta imune e considerada como um marcador de inflamação tem sido proposta na patogênese da endometriose. Recentemente, demonstramos que as concentrações de IL-6 no fluído peritoneal (FP) apresentam-se elevadas em mulheres com endometriose em comparação com mulheres hígidas (Andrade et al., 2017, in press). No entanto, a fonte do aumento de IL-6 no FP ainda não foi totalmente elucidada e seu potencial envolvimento com a endometriose merece maior investigação. No presente estudo, avaliamos a expressão proteica de IL-6 no tecido endometrial e sua concentração no FP de mulheres com endometriose pélvica e comparamos com mulheres hígidas. Um total de 18 pacientes com endometriose e 12 mulheres com pelve normal foram incluídas neste estudo caso-controle. Foram realizadas avaliações clínicas e laboratoriais. Os níveis de IL-6 no FP e a expressão proteica no tecido endometrial foram determinados utilizando ensaio imunoenzimático (ELISA) e imuno-histoquímica respectivamente. A concentração de IL-6 no FP foi significativamente mais elevada no grupo endometriose em comparação com o grupo controle [48,2 (36,7 - 89,9) ng/ml versus 23,1 (11,8 - 35,3) ng/ml, P = 0,002]. A expressão proteica de IL-6 foi positiva na maior parte das amostras de ambos os grupos sendo significativamente mais intensa no tecido endometriótico em comparação com a expressão no endométrio de mulheres com pelve normal (P < 0,05). Os resultados do presente estudo sugerem que a fonte da IL6 no FP de pacientes com endometriose possa ser, pelo menos em parte, proveniente dos focos endometrióticos. / Endometriosis is a chronic gynecological disease that affects at least 10% of women of reproductive age. It is characterized by growth of endometrial tissue outside the uterine cavity. Although its etiology remains controversial, studies suggest that immunological and inflammatory changes are associated with endometriosis and may contribute to the growth and survival of ectopic implants. As part of this process, an abnormal peritoneal microenvironment may be constituted by increased levels of immune cells. Among these, the elevation of proinflammatory cytokines in the peritoneal and systemic environment would participate in this process. Cytokines including interleukin-6 (IL-6), a glycoprotein that acts on the immune response and is considered as a marker of inflammation has been proposed to play a role in the pathogenesis of endometriosis. Recently, we have shown that IL-6 concentrations in the peritoneal fluid (PF) were higher in women with endometriosis compared to healthy women (Andrade et al., 2017, in press). However, the source of IL-6 in PF has not yet been fully elucidated and its potential involvement with endometriosis warrants further investigation. In the present study, we evaluated the protein expression of IL-6 in endometrial tissue and its concentration in PF of women with pelvic endometriosis and compared them with healthy women. A total of 18 patients with endometriosis and 12 women with normal pelvis were included in this case-control study. Clinical and laboratory evaluations were performed. IL-6 levels in PF and protein expression in endometrial tissue were determined using enzyme-linked immunosorbent assay (ELISA) and immunohistochemistry respectively. The concentrations of IL-6 in PF were significantly higher in the endometriosis group compared to the control group [48.2 (36.7-89.9) ng / ml versus 23.1 (11.8-35, 3) ng / ml, P = 0.002]. Protein expression of IL-6 was positive in most samples from both groups being significantly more intense in the endometriotic tissue of patients with endometriosis compared to the endometrial expression in women with normal pelvis (P < 0.05). The results of the present study suggest that the source of IL6 in the PF of patients with endometriosis may come, at least in part, from the endometriotic focus.
|
110 |
Velocidade de crescimento e níveis de interleucina-6 na artrite idiopática juvenil / Growth velocity and interleukin-6 levels in juvenile idiopathic arthritisSouza, Letícia da Silva January 2008 (has links)
Objetivos: Avaliar associações da velocidade de crescimento com marcadores inflamatórios e dose cumulativa de glicorticóide em uma coorte de pacientes com Artrite Idiopática Juvenil acompanhados por 1 ano. Material e Métodos: Foram avaliados 79 pacientes com AIJ segundo critérios da ILAR. A atividade clínica da doença foi classificada por médicos reumatologistas pediátricos. Os dados antropométricos foram mensurados e classificados de acordo com as normas da Organização Mundial da Saúde. Foram utilizadas curvas de velocidade de crescimento segundo Tanner; considerou-se baixa velocidade de crescimento valores de escore Z ≤ -2. Concentrações séricas de IL-6 foram mensuradas por ELISA no período basal, e valores acima de 1 pg/ml foram considerados elevados. Resultados: Baixa velocidade de crescimento teve uma prevalência de 25,3% e esteve associada com atividade da doença no período do seguimento (p=0,085), valores elevados de IL-6 (interleucina-6) (p=0,003), velocidade de sedimentação globular (VSG) (p=0,022) e proteína C reativa (PCR) (p=0,001) e maior dosagem cumulativa de glicocorticóide (0=0,044). Na regressão linear múltipla tendo como variável dependente a velocidade de crescimento, observou-se que somente os níveis elevados de IL-6 foram independente e negativamente associados com a velocidade de crescimento (p=0,025). Conclusão: Baixa velocidade de crescimento é altamente prevalente em crianças com AIJ. Níveis elevados de IL-6 têm um importante impacto negativo no crescimento desses pacientes, enquanto a exposição ao glicocorticóide total parece ser um fator secundário. / Objective: To evaluate associations of growth velocity with inflammatory markers and cumulative dose of glucocorticoid in a cohort of patients with Juvenile Idiopathic Arthritis (JIA) followed during 1 year. Methods: Seventy-nine patients were evaluated by criteria according to the ILAR. The disease activity was evaluated by a pediatric rheumatologist. The anthropometic data were measured and classified according to the World Health Organization standards. Growth velocity curves were used according to Tanner, values below the Z-score ≤ -2 were considered low growth velocity. Serum concentrations of IL-6 were measured by ELISA in the baseline period, and values over 1pg/ml were considered as elevated. Results: The prevalence of low growth velocity was 25.3%, and it was associated with: active disease on follow-up visit (p=0,085), elevated interleukin-6 (IL-6) (p=0,003), erythrocyte sedimentation rate (ESR) (p=0,022) and C-reactive protein (CRP) (p=0,001) and higher cumulative glucocorticoid doses (0=0,044). In the multiple linear regression with growth velocity as the dependent variable, only elevated IL-6 levels were independently and negatively associated with growth velocity (p=0,025). Conclusion: Low growth velocity is highly prevalent in children with JIA. Elevated IL-6 levels seem to have an important negative impact on growth in these children, while total glucocorticoid exposure appears to be a secondary factor.
|
Page generated in 0.0673 seconds